Syrris
Private Company
Total funding raised: $2.5M
Overview
Syrris is a privately-held, revenue-generating technology company that designs and manufactures sophisticated automated systems for flow and batch chemistry. Its product portfolio, including the Asia flow chemistry systems, Atlas HD, Orb, and Orb Pilot reactors, is used globally for process development, discovery chemistry, and scale-up, with a strong presence in top pharmaceutical companies. As part of the AGI Group, Syrris leverages a global distribution and manufacturing network to provide integrated solutions from lab to pilot scale, supported by a high customer satisfaction metric (NPS of 60) and over 600 peer-reviewed publications validating its technology.
Technology Platform
Modular automated systems for flow chemistry, batch chemistry reactors, chemical scale-up, and reaction calorimetry, enabling precise control and data-rich experimentation for chemical synthesis and process development.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes with other specialized providers of flow chemistry systems (e.g., Chemtrix, Vapourtec) and broader laboratory reactor/calorimetry companies (e.g., Büchi, Mettler Toledo). Its key differentiator is its integrated portfolio covering flow, batch, and scale-up, combined with the manufacturing and global reach of its parent company, AGI Group.